Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-21-017305
Filing Date
2021-04-01
Accepted
2021-04-01 16:16:14
Documents
3
Period of Report
2021-05-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A flgt-def14a_20210520.htm DEF 14A 639615
2 GRAPHIC gshjoufcyx3l000001.jpg GRAPHIC 68328
3 GRAPHIC gshjoufcyx3l000002.jpg GRAPHIC 81588
  Complete submission text file 0001564590-21-017305.txt   847439
Mailing Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780
Business Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780 626-350-0537
Fulgent Genetics, Inc. (Filer) CIK: 0001674930 (see all company filings)

EIN.: 812621304 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37894 | Film No.: 21798192
SIC: 8071 Services-Medical Laboratories